Comparing the meningococcal serogroup C immune response elicited by a tetanus toxoid conjugate quadrivalent meningococcal vaccine (MenACYW-TT) versus a quadrivalent or monovalent C tetanus toxoid conjugate meningococcal vaccine in healthy meningococcal vaccine-naïve toddlers: A randomised, controlled trial

MenACYW-TT (MenQuadfi®) is a quadrivalent meningococcal tetanus toxoid conjugate vaccine licensed in Europe for use in individuals ≥12 months. This study assessed whether serogroup C immune responses with MenACYW-TT were at least non-inferior, or superior, to those of quadrivalent meningococcal ACWY...

Descripción completa

Detalles Bibliográficos
Autores principales: Knuf, Markus, Rämet, Mika, Breinholt Stærke, Nina, Bertrand-Gerentes, Isabelle, Thollot, Yaël, B'Chir, Siham, Arroum, Habiba, Oster, Philipp
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Meningococcal – Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225511/
https://www.ncbi.nlm.nih.gov/pubmed/35445641
http://dx.doi.org/10.1080/21645515.2022.2052657

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225511/
https://www.ncbi.nlm.nih.gov/pubmed/35445641
http://dx.doi.org/10.1080/21645515.2022.2052657

Ejemplares similares